SLShivali Lakhani

Shivali Lakhani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shivali Lakhani has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Parental use of community pharmacies for childhood illness in the UK: A cross-sectional study of trust, help-seeking and readiness for Pharmacy First

    by Marhsa, Mengru Zhang, Mohammed Adam, Shivalk Lakhani, Austen

    Background Community pharmacies in the United Kingdom are increasingly recognised as accessible providers of primary care. Recent policy initiatives, including Pharmacy First, have expanded pharmacists’ roles in managing common conditions traditionally seen in general practice. However, contemporary evidence regarding parental use of pharmacies for child health remains limited. Objective To examine patterns of parental pharmacy use for child health, identify trusted sources of advice and assess demographic and behavioural predictors of pharmacy advice-seeking, trust and willingness to use pharmacy-delivered services. Methods A quota-based cross-sectional online survey of UK parents and caregivers (n = 545) was conducted as part of the Pharmacy PITCH project. Participants completed a 17-item questionnaire examining pharmacy use, advice-seeking behaviour, confidence in pharmacist-delivered advice, trust in pharmacy information and attitudes towards enhanced pharmacy services. Descriptive, bivariate and multivariable regression analyses were performed. Results Over half of respondents (55%) visited pharmacies at least monthly. Prescriptions (72%) and self-care medicines (54%) were the most common reasons for attendance, while 35% sought pharmacist advice. Pharmacies were most consulted for colds (32%), sore throat (34%) and skin rash (29%). Confidence in pharmacist advice was highest for self-limiting respiratory conditions (74–79%) and lowest for injuries (40–51%). Older respondents were more likely to seek pharmacy advice (OR 4.50, 95% CI 1.97–10.28 for age 55–64 vs 18–24), whereas males were less likely (OR 0.47, 95% CI 0.29–0.75). Willingness to vaccinate children at a pharmacy was high (88.5%) and associated with prior pharmacy advice-seeking behaviour. Conclusions UK parents frequently use community pharmacies for common childhood conditions and report substantial confidence in pharmacist-delivered advice. These findings support ongoing expansion of pharmacy-based paediatric minor illness and vaccination services within UK primary care.

  • Open Access

    Investigating the potential accessibility to HIV pre-exposure prophylaxis via community pharmacies and sexual health clinics: a scoping review of two integrated care systems in London

    by Aos Alaa, Datapwa Mujong, Shivali Lakhani, Marsha Alter, Austen El-Osta

    Background: Despite advancements in HIV prevention, barriers and disparities in accessing Pre-exposure Prophylaxis (PrEP) from specialist services persist. Community pharmacies, with their extensive reach, offer an opportunity to reduce these disparities and help end new HIV infections. Objective: This study aims to investigate the accessibility of HIV PrEP through community pharmacies and sexual health clinics (SHCs) across two London Integrated Care Systems (ICS) in the United Kingdom (UK). We also sought to assess the potential for community pharmacies to enhance access to PrEP and to address existing gaps in PrEP provision in the UK to gauge the potential for community pharmacies to facilitate easier access to PrEP. Methods: We mapped the distribution of pharmacies, PrEP clinics, and SHCs across 11 local authority areas in London, covering North West London ICS and three catchment areas from North Central London ICS using publicly available data, including postcode data. Our selection process for sources of evidence was guided by a set of predefined criteria aimed at identifying community pharmacies and SHCs within the targeted ICSs for their relevance to HIV PrEP accessibility. Two reviewers systematically charted data from each included source. Information extracted included the name of the pharmacy or clinic, address, contact details and operating hours. Results: Our data collection, spanning from April to July 2022, included 692 community pharmacies. The study revealed that 543 (78.5%) of these pharmacies offered sexual health services, with a significant proportion categorised at Tier 2 according to the Umbrella Sexual Health Model, indicating they are well-positioned to offer PrEP services. The mapping showed an uneven distribution of PrEP and sexual health clinics, with community pharmacies widely accessible and offering longer service hours. Conclusion: The findings highlight the critical role community pharmacies could play in providing PrEP, addressing gaps in accessibility, and reducing HIV transmission risks, thus potentially facilitating easier access to PrEP. This study supports the need for policy adjustments to enable community pharmacies to dispense PrEP, aligning with public health goals for broader access to HIV preventative measures.


  • Open Access

    Investigating facilitators and barriers to the routine provision of HIV PrEP in community pharmacies in London

    by Marsha Alter, Shivali Lakhani, Aos Alaa, Manisha Karki, Eva Riboli-Sasco, Austen El-Osta

    Background: The United Kingdom’s (UK) integration of Pre-exposure Prophylaxis (PrEP) into community pharmacies presents an alternative avenue for supporting Human Immunodeficiency Virus (HIV) prevention. Despite its effectiveness, PrEP's accessibility remains hindered by various barriers within community settings. The aim of this study was to explore the perspectives of pharmacy team members regarding the barriers and facilitators to the routine provision of PrEP in community pharmacies in the UK, as well as any recommendations for mitigating these challenges. Methods: Exploratory mixed-method cross-sectional study utilising an online survey and semi-structured interviews with community pharmacists and non-pharmacist team members across the North Thames area of London, England. A convenience sample of 110 pharmacy team members participated in the study, including both pharmacists and non-pharmacists. Two pharmacy technicians and eight pharmacists took part in semi-structured interviews. Data collection involved a cross-sectional online survey and semi-structured interviews. The survey collected data such as demographic characteristics, knowledge, and attitudes towards PrEP provision, while interviews explored in-depth perceptions, experiences and recommendations. Results: A significant proportion of respondents expressed a lack of confidence and knowledge regarding PrEP, with training identified as a critical need for facilitating PrEP provision. Additionally, the study highlighted the potential of community pharmacies to increase accessibility of PrEP due to their geographical reach and the trust placed in pharmacists. Conclusion: The study demonstrates an interest from community pharmacies in London in providing a commissioned PrEP supply service. However, this would need to be in conjunction with training programmes and public health campaigns to equip community pharmacies for effective PrEP provision. Enhancing pharmacists' competencies and raising public awareness could significantly support the current HIV prevention strategies in the UK.


  • Open Access

    Investigating barriers and enablers to the routine provision of HIV PrEP in community pharmacies in London

    by Marsha Alter, Shivali Lakhani, Aos Alaa, Manisha Karki, Eva Riboli-Sasco, Austen El-Osta

    Background The UK's integration of Pre-exposure Prophylaxis (PrEP) into community pharmacies presents a promising avenue for enhancing HIV prevention. Despite its effectiveness, PrEP's accessibility remains hindered by various barriers within community settings. In this study, we aimed to explore the perspectives of pharmacy team members regarding the barriers and facilitators to the routine provision of HIV PrEP in UK community pharmacies, as well as their recommendations to mitigating these challenges. Methods A mixed-method study utilising an online survey and semi-structured interviews with community pharmacists and non-pharmacist team members across the UK. A convenience sample of 110 pharmacy team members participated in the study, including both pharmacists and non-pharmacist. Two pharmacy technicians and eight pharmacists took part in semi-structured interviews. Data collection involved a cross-sectional online survey and semi-structured interviews. The survey assessed demographic characteristics, knowledge and attitudes towards PrEP provision, while interviews explored in-depth perceptions, experiences and recommendations. Results A significant proportion of respondents expressed a lack of confidence and knowledge regarding PrEP, with training identified as a critical need for facilitating PrEP provision. Additionally, the study highlighted the potential of community pharmacies to increase PrEP accessibility due to their geographical reach and the trust placed in pharmacists. Conclusion The study highlights the necessity for targeted training programs and public health campaigns to equip community pharmacies for effective PrEP provision. Enhancing pharmacists' competencies and public awareness could significantly impact HIV prevention strategies in the UK.

  • Open Access

    Correction to: Demographic and psychological predictors of community pharmacists’ cancer-related conversations with patients: a cross-sectional analysis and survey study

    by Robert S. Kerrison, Anna Robinson, Hanna Skrobanski, Ghalia Kayal, Aradhna Kaushal, Charlotte Ide-Walters, Adam Todd, Andrew Husband, Shivali Lakhani, Marsha Alter, et al.